Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: johnny weissman who wrote (605)	4/16/1998 10:28:00 AM
From: yosi s	Respond to of 1491

One should read carefully the reply PARS officially has to distance itself from the post. Answer post = read post. So they follow it. The use of PARS is best through its Internet site and news releases. Interviews etc. I do not know if posting is same. Any one care to give legal opinion.

To: johnny weissman who wrote (605)	4/16/1998 11:01:00 AM
From: Ariella	Read Replies (1) \| Respond to of 1491

PARS is correct to distance itself from fraudulent use of Dr. Aviv's name. Read back posts here: The CFO, Bob Cook, receives e-mail from the PARS website, but who would believe a top official would post on the boards given the liability he/she would incur? That's why Blue Sky paragraphs are appended to every news release and even SEC documents. I hope they will notify Yahoo that someone has done that. Bland though the message was, that's a deliberate attempt to fool investors and can't be in sync with the terms of service rules generally accepted by most board posters/ readers. We should instead be discussing the import of the argument with the Chief Scientist's office in Israel about R&D funding..... Ariella